InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Turka Laurence A., Directeur Scientifique. Officer active across 1 company, notably Rubius Therapeutics, Inc.. Aggregated, 2 filings have been logged. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Laurence A. Turka is the Chief Scientific Officer at Rubius Therapeutics, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is essential in guiding innovative projects and ensuring the success of therapies developed by Rubius.